Searched for
TRIVITRON HEALTHCARE IPO
Neuberg Diagnostics said to eye $350 million India IPO in 2026Neuberg Diagnostics is reportedly planning a $350 million IPO next year, joining India's booming stock market. Founder GSK Velu also intend...- Kotak Pre-IPO fund to buy into diagnostic chain NeubergKotak Pre IPO Opportunities Fund is in advanced talks to acquire a 15% stake in Neuberg Diagnostics for approximately Rs 450 crore. Neuberg...
- Neuberg Diagnostics plans to raise $100 million to fund acquisitionsNeuberg, which runs a pan-India diagnostic chain, has appointed O3 Capital as the investment banker and is currently in talks with potentia...
- True North buys into Biocon Biologics, deal values firm at around $3.5 billionTrue North has acquired about 3 per cent of Biocon Biologics India Ltd (BBIL), a wholly owned subsidiary of Biocon, for $100 million, valui...
- Trivitron, Neuberg may expand to Africa, MideastGSK Velu, founder of both companies, is looking at aggressively acquiring pathology chains and medical equipment makers in these markets th...
- Why Vishal Nevatia's IVFA needs to perform well to keep to its reputationOver the years, IVFA has taken unusual bets. It typically chases small controloriented deals, besides the conventional growth equity transa...
- Top PEs including Apax Partners & Temasek eye a deal in Metropolis HealthcareThe dealmaking in Metropolis coincides with IPO plans of other players, notably Dr Lal Pathlabs, SRL and Thyrocare, all of whom could list ...
Load More